Silexion Therapeutics Ltd. (SLXN) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Silexion Therapeutics Ltd. (SLXN) quarterly cash flow statement — complete operating, investing & financing history

Quarterly statement

SLXN Cash Flow Statement

Silexion Therapeutics Ltd. (SLXN) cash flow statement — 6-year operating, investing & financing cash flows

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q1'21

Cash from Operations	-2.92M	-3.65M	-3.02M	-2.84M	-2.51M	-2.45M	-2.93M	-2.65M	-1.06M	-1.75M	-5.02M	-685K	-13.97K	531.83K	660.3K	354.55K	-57.86K	-140.56K	-373.46K	-805.18K
Operating CF Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating CF Growth %	-16.67%	-48.63%	-3.08%	-7.16%	-135.4%	-40.01%	41.74%	-287.3%	-7522.39%	-429.43%	-860.62%	-293.2%	75.85%	478.37%	276.8%	-	-	82.54%	-	-
Net Income	-3.55M	-2.73M	-4.41M	-3.26M	-2.5M	-1.74M	-1.75M	-11.86M	-1.49M	-1.42M	-1.73M	-809K	162.95K	313.19K	494.41K	292.58K	42.69K	-245.66K	-241.77K	-97.75K
Depreciation & Amortization	3K	2K	3K	4K	3K	4K	-12K	22K	7K	8K	6K	10K	0	0	0	0	0	0	0	0
Stock-Based Compensation	197K	345K	0	38K	37K	21K	31.97K	5.8M	32K	32	0	32K	0	0	0	0	0	0	0	0
Deferred Taxes	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Non-Cash Items	-135K	4K	88K	-16K	229K	81K	-251.97K	3.82M	83K	167.97K	-3.42M	107K	-418	-4.88K	10.39K	-9.56K	-36.35K	-95.19K	-189.45K	5.78K
Working Capital Changes	561K	-1.26M	1.3M	393K	-273K	-824K	-947K	-430K	302K	-505K	123.68K	-25K	-176.5K	223.52K	155.49K	71.53K	-64.2K	200.29K	57.75K	-713.21K
Change in Receivables	0	0	0	16K	0	4K	0	0	2K	0	0	24K	0	0	0	0	0	0	0	0
Change in Inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Payables	268K	65K	-57K	254K	-30K	-207K	131K	517K	37K	-75K	0	131K	0	0	0	0	0	0	0	0
Cash from Investing	-1K	0	-7K	0	-1K	-6K	0	-16K	0	-6K	573K	72K	0	0	0	0	0	0	0	0
Capital Expenditures	0	0	-2K	0	-1K	-6K	0	-16K	0	-6K	-12K	-6K	0	0	0	0	0	0	0	0
CapEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisitions	0	0	0	0	0	0	0	0	0	0	78K	0	0	0	0	0	0	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	0	0	0	0	0	0	0	0	507K	78K	0	0	0	0	0	0	0	0
Cash from Financing	2.74M	83K	-221K	8.62M	-195K	7.43M	2.18M	2.92M	0	0	112.12M	0	535K	-90.37M	190K	350K	60K	290K	300K	116.1M
Debt Issued (Net)	0	0	0	0	0	-696K	-250K	-505K	0	0	-1.3M	0	535K	385K	190K	350K	60K	290K	300K	-149.99K
Equity Issued (Net)	2.98M	0	-221K	8.62M	-195K	5M	2.43M	620K	0	0	113.43M	0	0	-90.75M	0	0	0	0	0	118.8M
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	0	0	0	0	112.9M	0	0	-90.75M	0	0	0	0	0	0
Other Financing	-243K	83K	0	0	0	3.13M	0	2.81M	0	0	0	0	0	0	0	0	0	0	0	-2.55M
Net Change in Cash	-182K	-3.58M	-3.25M	5.78M	-2.69M	4.96M	-753K	276K	-1.08M	-1.81M	4.56M	-679K	-36.97K	11.79K	-142.62K	184.53K	-161.2K	140.06K	-75.64K	294.99K
Free Cash Flow	-2.92M	-3.65M	-3.02M	-2.84M	-2.51M	-2.46M	-2.93M	-2.67M	-1.06M	-1.76M	-5.03M	-691K	-13.97K	531.83K	660.3K	354.55K	-57.86K	-140.56K	-373.46K	-805.18K
FCF Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FCF Growth %	-16.63%	-48.27%	-3.14%	-6.52%	-135.49%	-39.87%	41.88%	-286.25%	-7523.48%	-430.56%	-862.44%	-294.89%	75.86%	478.37%	276.81%	-	-	82.54%	-	-
FCF per Share	-4.26	-11.29	-9.65	-25.10	-43.28	-54.41	-237.42	-618.25	-1431.45	-2359.73	-51.84	-1.25	-0.02	0.44	0.40	0.21	-0.04	-0.09	-0.23	-0.49
FCF Conversion (FCF/Net Income)	0.82x	1.33x	0.68x	0.87x	1.00x	1.41x	1.67x	0.22x	0.72x	1.28x	2.91x	0.87x	-0.09x	-687.12x	1.34x	1.21x	-1.36x	0.57x	1.54x	8.24x
Interest Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0